CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Other Comprehensive Income (Loss) [Member]	Retained Earnings (Accumulated Deficit) [Member]	Retained Earnings (Accumulated Deficit) [Member] Series A Preferred Stock [Member]	Treasury Stock [Member]	Noncontrolling Interest [Member]	Noncontrolling Interest [Member] Series A Preferred Stock [Member]
Balance at Sep. 30, 2017		$ 9,000	$ 21,406,000	$ (539,000)	$ (919,000)		$ (986,000)	$ 1,454,000
Balance (in shares) at Sep. 30, 2017		17,893,763					810,160
Impact of change in accounting policy					0
Xcede stock surrender of Series A Preferred						$ 0			$ 0
Issuance of shares of common stock under employee stock purchase plan			8,000
Issuance of shares of common stock under employee stock purchase plan (in shares)		7,956
Stock-based compensation costs			221,000					9,000
Stock-based compensation costs (in shares)		107,152
Foreign currency translation adjustment				257,000
Net income (loss)	$ 383,000				491,000			(108,000)
Balance at Mar. 31, 2018	21,303,000	$ 9,000	21,635,000	(282,000)	(428,000)		$ (986,000)	1,355,000
Balance (in shares) at Mar. 31, 2018		18,008,871					810,160
Balance at Dec. 31, 2017	21,303,000	$ 9,000	21,499,000	(504,000)	(1,751,000)		$ (986,000)	1,383,000
Balance (in shares) at Dec. 31, 2017		17,929,183					810,160
Impact of change in accounting policy					0
Xcede stock surrender of Series A Preferred						0			0
Issuance of shares of common stock under employee stock purchase plan			4,000
Issuance of shares of common stock under employee stock purchase plan (in shares)		3,536
Stock-based compensation costs			132,000					5,000
Stock-based compensation costs (in shares)		76,152
Foreign currency translation adjustment				222,000
Net income (loss)	1,290,000				1,323,000			(33,000)
Balance at Mar. 31, 2018	21,303,000	$ 9,000	21,635,000	(282,000)	(428,000)		$ (986,000)	1,355,000
Balance (in shares) at Mar. 31, 2018		18,008,871					810,160
Balance at Sep. 30, 2018	22,328,000	$ 9,000	21,865,000	(700,000)	841,000		$ (986,000)	1,299,000
Balance (in shares) at Sep. 30, 2018		18,152,074					810,160
Impact of change in accounting policy					22,000
Xcede stock surrender of Series A Preferred						16,000			(16,000)
Issuance of shares of common stock under employee stock purchase plan			9,000
Issuance of shares of common stock under employee stock purchase plan (in shares)		11,830
Stock-based compensation costs			186,000					4,000
Stock-based compensation costs (in shares)		137,312
Foreign currency translation adjustment				4,000
Net income (loss)	(30,000)				(17,000)			(13,000)
Balance at Mar. 31, 2019	22,523,000	$ 9,000	22,060,000	(696,000)	862,000		$ (986,000)	1,274,000
Balance (in shares) at Mar. 31, 2019		18,301,216					810,160
Balance at Dec. 31, 2018	22,523,000	$ 9,000	21,946,000	(841,000)	770,000		$ (986,000)	1,292,000
Balance (in shares) at Dec. 31, 2018		18,198,121					810,160
Impact of change in accounting policy					0
Xcede stock surrender of Series A Preferred						$ 16,000			$ (16,000)
Issuance of shares of common stock under employee stock purchase plan			4,000
Issuance of shares of common stock under employee stock purchase plan (in shares)		5,512
Stock-based compensation costs			110,000					2,000
Stock-based compensation costs (in shares)		97,583
Foreign currency translation adjustment				145,000
Net income (loss)	72,000				76,000			(4,000)
Balance at Mar. 31, 2019	$ 22,523,000	$ 9,000	$ 22,060,000	$ (696,000)	$ 862,000		$ (986,000)	$ 1,274,000
Balance (in shares) at Mar. 31, 2019		18,301,216					810,160